Nationwide Children’s Hospital is on track to initiate a Phase 1/2a clinical trial in individuals with Duchenne muscular dystrophy by year-end 2017. Source: BioSpace

Novartis announced they have expanded their collaboration with the Banner Alzheimer’s Institute to launch a new clinical trial in ALZ's. Source: BioSpace

Neurocrine's third-quarter financial results didn't just impress, they blew everybody away. Source: BioSpace

GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace

Mallinckrodt has agreed to buy Ocera Therapeutics in a deal that could hit $117M. Source: BioSpace

Physicians collaborating with Retrotope previously received approval from the FDA to test RT001 in Expanded Access trials of two patients having Infantile Neuroaxonal Dystrophy. Source: BioSpace

For most biopharma sponsors, the crux of their challenge is how to identify an adequate number of evaluable patients to sufficiently power their late phase clinical research. Source: BioSpace

Aisling Capital today announced the closing of its newest fund, with $280M in committed capital. Source: BioSpace

Dicerna and Boehringer Ingelheim today announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics for the treatment of chronic liver diseases. Source: BioSpace

Despite Brandicourt's positive spin, investors were displeased as the company's financial report fell shy of analysts' expectations. Source: BioSpace